1.13
price up icon3.66%   0.0399
after-market Dopo l'orario di chiusura: 1.13
loading
Precedente Chiudi:
$1.0901
Aprire:
$1.18
Volume 24 ore:
47,431
Relative Volume:
0.18
Capitalizzazione di mercato:
$3.06M
Reddito:
$31,800
Utile/perdita netta:
$-37.83M
Rapporto P/E:
-1.5915
EPS:
-0.71
Flusso di cassa netto:
$-30.64M
1 W Prestazione:
+4.63%
1M Prestazione:
-14.39%
6M Prestazione:
-97.27%
1 anno Prestazione:
-97.58%
Intervallo 1D:
Value
$1.10
$1.18
Intervallo di 1 settimana:
Value
$1.0204
$1.18
Portata 52W:
Value
$0.85
$124.80

Eyenovia Inc Stock (EYEN) Company Profile

Name
Nome
Eyenovia Inc
Name
Telefono
813-766-9539
Name
Indirizzo
295 MADISON AVENUE,, NEW YORK, NY
Name
Dipendente
57
Name
Cinguettio
@eyenovia
Name
Prossima data di guadagno
2025-03-26
Name
Ultimi documenti SEC
Name
EYEN's Discussions on Twitter

Confronta EYEN con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
EYEN
Eyenovia Inc
1.13 3.06M 31,800 -37.83M -30.64M -0.71
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
492.47 125.74B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
599.76 61.57B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
600.51 36.40B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
242.61 30.36B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
256.16 24.89B 3.81B -644.79M -669.77M -6.24

Eyenovia Inc Stock (EYEN) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-11-18 Downgrade H.C. Wainwright Buy → Neutral
2021-03-01 Iniziato Northland Capital Outperform
2020-02-03 Downgrade Oppenheimer Outperform → Perform

Eyenovia Inc Borsa (EYEN) Ultime notizie

pulisher
Apr 15, 2025

Eyenovia Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Apr 15, 2025
pulisher
Apr 15, 2025

EYENOVIA, INC. SEC 10-K Report - TradingView

Apr 15, 2025
pulisher
Apr 15, 2025

Eyenovia Inc expected to post a loss of $7.20 a shareEarnings Preview - TradingView

Apr 15, 2025
pulisher
Apr 11, 2025

Eyenovia (EYEN) Advances with Optejet User Filled Device Development | EYEN Stock News - GuruFocus

Apr 11, 2025
pulisher
Apr 11, 2025

Eyenovia Provides Development Update on Optejet User Filled Devi - GuruFocus

Apr 11, 2025
pulisher
Apr 10, 2025

Eyenovia nears regulatory submission for Optejet UFD device By Investing.com - Investing.com South Africa

Apr 10, 2025
pulisher
Apr 10, 2025

Eyenovia Provides Development Update on Optejet User Filled Device (UFD) - The Manila Times

Apr 10, 2025
pulisher
Apr 10, 2025

Eyenovia nears regulatory submission for Optejet UFD device - Investing.com

Apr 10, 2025
pulisher
Apr 10, 2025

Eyenovia provides development update on Optejet UFD - TipRanks

Apr 10, 2025
pulisher
Apr 10, 2025

Revolutionary Eye Drug Device Passes Critical Tests: Eyenovia's Game-Changing Innovation - Stock Titan

Apr 10, 2025
pulisher
Apr 09, 2025

Mydriasis Market Predicted to See Upsurge Through 2034, - openPR.com

Apr 09, 2025
pulisher
Apr 09, 2025

Mydriasis Market Predicted to See Upsurge Through 2034, Highlights DelveInsight | Viatris/Ocuphire Pharma, Eyenovia, Rayner Surgical/Omeros, Eyenovia Inc., Taejoon Pharma - Barchart.com

Apr 09, 2025
pulisher
Mar 31, 2025

Eyenovia Delays Yearly Report Filing - TipRanks

Mar 31, 2025
pulisher
Mar 26, 2025

Deal Watch: Eyenovia Looks At New Direction In Proposed Merger With Betaliq - insights.citeline.com

Mar 26, 2025
pulisher
Mar 21, 2025

Eyenovia falls on plans to seek reverse merger - MSN

Mar 21, 2025
pulisher
Mar 21, 2025

Eyenovia Enters Into Non-Binding Letter of Intent to Effect Reverse Merger With Betaliq - VisionMonday.com

Mar 21, 2025
pulisher
Mar 20, 2025

Eyenovia And Betaliq Announce Potential Reverse Merger - Nasdaq

Mar 20, 2025
pulisher
Mar 20, 2025

Eyenovia Shares Drop 14% Amid Betaliq Merger Talks - Yahoo

Mar 20, 2025
pulisher
Mar 20, 2025

Eyenovia stock falls on reverse merger plans (EYEN:NASDAQ) - Seeking Alpha

Mar 20, 2025
pulisher
Mar 20, 2025

Eyenovia falls after plans to merge with private firm Betaliq - TradingView

Mar 20, 2025
pulisher
Mar 20, 2025

Eyenovia Plans All-Stock Reverse Merger With Betaliq - MarketWatch

Mar 20, 2025
pulisher
Mar 20, 2025

Eyenovia and Betaliq Explore Merger to Form New Ophthalmic Company Combining Innovative Drug Delivery Technologies for Glaucoma Treatment - Nasdaq

Mar 20, 2025
pulisher
Mar 20, 2025

Eyenovia Enters into Non-Binding Letter of Intent to Effect Reverse Merger with Betaliq - GlobeNewswire

Mar 20, 2025
pulisher
Mar 20, 2025

Strategic Merger Alert: Eyenovia and Betaliq Join Forces to Revolutionize Eye Care Delivery - StockTitan

Mar 20, 2025
pulisher
Mar 15, 2025

EYENOVIA Earnings Preview: Recent $EYEN Insider Trading, Hedge Fund Activity, and More - Nasdaq

Mar 15, 2025
pulisher
Mar 07, 2025

Eyenovia, Inc. to Host Earnings Call - ACCESS Newswire

Mar 07, 2025
pulisher
Feb 28, 2025

Eyenovia regains compliance with Nasdaq - MSN

Feb 28, 2025
pulisher
Feb 28, 2025

Eyenovia, Inc. (NASDAQ:EYEN) Short Interest Up 346.2% in February - The AM Reporter

Feb 28, 2025
pulisher
Feb 27, 2025

Eyenovia Regains Compliance with All Nasdaq Continued Listing Requirements - GlobeNewswire

Feb 27, 2025
pulisher
Feb 27, 2025

Eyenovia Shares Surge After Regaining Nasdaq Compliance: What's Going On? - Benzinga

Feb 27, 2025
pulisher
Feb 26, 2025

Eyenovia regains Nasdaq compliance, eyes strategic options By Investing.com - Investing.com Canada

Feb 26, 2025
pulisher
Feb 26, 2025

Eyenovia regains Nasdaq compliance, eyes strategic options - Investing.com India

Feb 26, 2025
pulisher
Feb 26, 2025

Eyenovia shareholders approve reverse stock split and additional stock reserve - MSN

Feb 26, 2025
pulisher
Feb 26, 2025

Eyenovia Escapes Delisting Threat: What's Next for the Optejet Developer? - StockTitan

Feb 26, 2025
pulisher
Feb 26, 2025

Eyenovia regains Nasdaq compliance with stock bid price By Investing.com - Investing.com Australia

Feb 26, 2025
pulisher
Feb 25, 2025

Eyenovia regains Nasdaq compliance with stock bid price - Investing.com

Feb 25, 2025
pulisher
Feb 25, 2025

Eyenovia, Inc. Announces Debt Restructuring, Including Amendment to Senior Secured Debt to Improve Liquidity - Vision Monday

Feb 25, 2025
pulisher
Feb 24, 2025

Eyenovia defers debt payments to bolster liquidity By Investing.com - Investing.com Nigeria

Feb 24, 2025
pulisher
Feb 24, 2025

Eyenovia announces debt restructuring, improving cash runway - MSN

Feb 24, 2025
pulisher
Feb 24, 2025

Eyenovia, Inc. Announces Debt Restructuring Including - GlobeNewswire

Feb 24, 2025
pulisher
Feb 24, 2025

Eyenovia defers loan payments, may convert debt to equity By Investing.com - Investing.com Canada

Feb 24, 2025
pulisher
Feb 24, 2025

Eyenovia defers loan payments, may convert debt to equity - Investing.com India

Feb 24, 2025
pulisher
Feb 24, 2025

Eyenovia defers debt payments to bolster liquidity - Investing.com India

Feb 24, 2025

Eyenovia Inc Azioni (EYEN) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$20.54
price up icon 2.04%
$68.96
price down icon 2.60%
$32.03
price up icon 1.07%
$36.70
price up icon 10.44%
$120.54
price up icon 4.97%
biotechnology ONC
$256.16
price up icon 2.82%
Capitalizzazione:     |  Volume (24 ore):